<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40806442</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>15</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>29</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Time-Restricted Eating Improves Glycemic Control in Patients with Type 2 Diabetes: A Meta-Analysis and Systematic Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7310</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms26157310</ELocationID><Abstract><AbstractText>Time-restricted eating (TRE), a dietary strategy that aligns food intake with circadian rhythms, has emerged as a promising non-pharmacological approach for improving glycemic control in patients with type 2 diabetes. This systematic review and meta-analysis evaluated the effects of TRE on glycemic outcomes by analyzing eight randomized controlled trials involving 312 participants with type 2 diabetes or impaired fasting glucose. Meta-analyses of six eligible studies demonstrated that TRE significantly reduced fasting glucose (mean difference [MD]: -0.74 mmol/L; 95% CI: -1.13 to -0.36) and glycated hemoglobin (&#x394;HbA1c) (MD: -0.11%; 95% CI: -0.15 to -0.07) and increased time in range (TIR) for blood glucose (MD: +10.51%; 95% CI: 6.81 to 14.21). Improvements in fasting glucose and HbA1c were modest but consistent, while the increase in TIR showed no between-study heterogeneity, suggesting a robust and reproducible benefit of TRE on glycemic stability. These findings support the clinical feasibility and effectiveness of TRE as a dietary intervention in diabetes management. However, further high-quality trials with standardized protocols and longer follow-up are needed to confirm long-term efficacy and inform guidelines.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nam</LastName><ForeName>Taegwang</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0533-9081</Identifier><AffiliationInfo><Affiliation>College of Korean Medicine, Woosuk University, Jeonju 54986, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Hyeongbin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>College of Korean Medicine, Woosuk University, Jeonju 54986, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4607-1328</Identifier><AffiliationInfo><Affiliation>KM Data Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Yongtaek</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Korean Medicine, Woosuk University, Jeonju 54986, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KSN2511021</GrantID><Agency>Korea Institute of Oriental Medicine</Agency><Country/></Grant><Grant><GrantID>RS-2023-00254007</GrantID><Agency>Korean government (MSIT)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000178" MajorTopicYN="N">diet therapy</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085002" MajorTopicYN="Y">Glycemic Control</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="Y">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005215" MajorTopicYN="N">Fasting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HbA1c</Keyword><Keyword MajorTopicYN="N">diabetes mellitus</Keyword><Keyword MajorTopicYN="N">fasting glucose</Keyword><Keyword MajorTopicYN="N">glycemic control</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">time in range</Keyword><Keyword MajorTopicYN="N">time-restricted eating</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>31</Day><Hour>20</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40806442</ArticleId><ArticleId IdType="pmc">PMC12346854</ArticleId><ArticleId IdType="doi">10.3390/ijms26157310</ArticleId><ArticleId IdType="pii">ijms26157310</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zheng Y., Ley S.H., Hu F.B. Global Aetiology and Epidemiology of Type 2 Diabetes Mellitus and Its Complications. Nat. Rev. Endocrinol. 2018;14:88&#x2013;98. doi: 10.1038/nrendo.2017.151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2017.151</ArticleId><ArticleId IdType="pubmed">29219149</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee M., Khursheed R., Yadav A.K., Singh S.K., Gulati M., Pandey D.K., Prabhakar P.K., Kumar R., Porwal O., Awasthi A., et al. A Systematic Review on Synthetic Drugs and Phytopharmaceuticals Used to Manage Diabetes. Curr. Diabetes Rev. 2020;16:340&#x2013;356. doi: 10.2174/1573399815666190822165141.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573399815666190822165141</ArticleId><ArticleId IdType="pubmed">31438829</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolb H., Martin S. Environmental/Lifestyle Factors in the Pathogenesis and Prevention of Type 2 Diabetes. BMC Med. 2017;15:131. doi: 10.1186/s12916-017-0901-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-017-0901-x</ArticleId><ArticleId IdType="pmc">PMC5516328</ArticleId><ArticleId IdType="pubmed">28720102</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckel R.H., Bornfeldt K.E., Goldberg I.J. Cardiovascular Disease in Diabetes, beyond Glucose. Cell Metab. 2021;33:1519&#x2013;1545. doi: 10.1016/j.cmet.2021.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.07.001</ArticleId><ArticleId IdType="pmc">PMC8411849</ArticleId><ArticleId IdType="pubmed">34289375</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J., Ortiz A., Castellino J., Kinney J. Diabetes: Risk Factor and Translational Therapeutic Implications for Alzheimer&#x2019;s Disease. Eur. J. Neurosci. 2022;56:5727&#x2013;5757. doi: 10.1111/ejn.15619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.15619</ArticleId><ArticleId IdType="pmc">PMC9393901</ArticleId><ArticleId IdType="pubmed">35128745</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei C., Duan J., Ge G., Zhang M. Association between Neonatal Hyperglycemia and Retinopathy of Prematurity: A Meta-Analysis. Eur. J. Pediatr. 2021;180:3433&#x2013;3442. doi: 10.1007/s00431-021-04140-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04140-w</ArticleId><ArticleId IdType="pubmed">34114080</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozakova M., Palombo C. Diabetes Mellitus, ArterialWall, and Cardiovascular Risk Assessment. Int. J. Env. Res. Public Health. 2016;13:201. doi: 10.3390/ijerph13020201.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph13020201</ArticleId><ArticleId IdType="pmc">PMC4772221</ArticleId><ArticleId IdType="pubmed">26861377</ArticleId></ArticleIdList></Reference><Reference><Citation>Shikata K., Ninomiya T., Kiyohara Y. Diabetes Mellitus and Cancer Risk: Review of the Epidemiological Evidence. Cancer Sci. 2013;104:9&#x2013;14. doi: 10.1111/cas.12043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cas.12043</ArticleId><ArticleId IdType="pmc">PMC7657146</ArticleId><ArticleId IdType="pubmed">23066889</ArticleId></ArticleIdList></Reference><Reference><Citation>ElSayed N.A., Aleppo G., Aroda V.R., Bannuru R.R., Brown F.M., Bruemmer D., Collins B.S., Cusi K., Das S.R., Gibbons C.H., et al. Summary of Revisions: Stand. Care Diabetes&#x2014;2023. Diabetes Care. 2023;46:S5&#x2013;S9. doi: 10.2337/dc23-Srev.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc23-Srev</ArticleId><ArticleId IdType="pmc">PMC9810459</ArticleId><ArticleId IdType="pubmed">36507641</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends in the prevalence of diabetes, 2013&#x2013;2022. Public Health Weekly Rep. 2024;17:1860&#x2013;1861. doi: 10.56786/PHWR.2024.17.43.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.56786/PHWR.2024.17.43.4</ArticleId></ArticleIdList></Reference><Reference><Citation>Termannsen A.-D., Varming A., Hansen G.S., Bjerre N., Persson F., Bagger J.I., Hansen D.L., Ewers B., J&#xf8;rgensen N.B., Blond M.B., et al. Time-Restricted Eating Is a Feasible Dietary Strategy in the Treatment of Complicated Type 2 Diabetes: The RESET2 Pilot Study. J. Nutr. Educ. Behav. 2025;000:1&#x2013;11. doi: 10.1016/j.jneb.2025.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneb.2025.03.012</ArticleId><ArticleId IdType="pubmed">40304655</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y.J., Turner L., Teong X.T., Zhao L., Variji A., Wittert G.A., Thompkins S., Vincent A.D., Grosser L., Young M.J., et al. Comparing the Effectiveness of Calorie Restriction with and without Time-Restricted Eating on the Circadian Regulation of Metabolism: Rationale and Protocol of a Three-Arm Randomised Controlled Trial in Adults at Risk of Type 2 Diabetes. Nutr. Res. 2025;138:33&#x2013;44. doi: 10.1016/j.nutres.2025.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nutres.2025.03.009</ArticleId><ArticleId IdType="pubmed">40288139</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehghani S., Karimi P., Tarei N.N., Masoumvand M., Manesh M.A.N., Ramezani E., Askari V.R. Comparison of the Effect of Intermittent Fasting with Mediterranean Diet on Glycemic, Lipid, and Anthropometric Indices in Type 2 Diabetes: A Review of Randomized Controlled Trials. Curr. Hypertens. Rev. 2025;21:1&#x2013;12. doi: 10.2174/0115734021351456250326051146.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0115734021351456250326051146</ArticleId><ArticleId IdType="pubmed">40231524</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S., Cienfuegos S., Ezpeleta M., Pavlou V., Corapi S., Runchey M.-C., Alexandria S.J., Tussing-Humphreys L., Varady K.A. Time-Restricted Eating Versus Daily Calorie Restriction: Effects on Inflammatory Markers over 12 Months in Adults with Obesity. Nutrients. 2025;17:1130. doi: 10.3390/nu17071130.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu17071130</ArticleId><ArticleId IdType="pmc">PMC11990601</ArticleId><ArticleId IdType="pubmed">40218888</ArticleId></ArticleIdList></Reference><Reference><Citation>Catenacci V.A., Ostendorf D.M., Pan Z., Kaizer L.K., Creasy S.A., Zaman A., Caldwell A.E., Dahle J., Swanson B., Breit M.J., et al. The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months. Ann. Intern. Med. 2025;178:634&#x2013;644. doi: 10.7326/ANNALS-24-01631.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/ANNALS-24-01631</ArticleId><ArticleId IdType="pubmed">40163873</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo-Garcia A.P., Radford B.E., Hall R.C., Broome S.C., Tee N., Arthur B., Janssens K., Johnston R.D., Halson S.L., Devlin B.L., et al. Combined Effects of Time-Restricted Eating and Exercise on Short-Term Blood Glucose Management in Individuals with Type 2 Diabetes Mellitus: The TREx Study, a Randomised Controlled Trial. Diabetes Res. Clin. Pract. 2025;222:112081. doi: 10.1016/j.diabres.2025.112081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2025.112081</ArticleId><ArticleId IdType="pubmed">40064299</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun L., Haumann H., Polanc A., Koch R., Feil E., Klein A., Salm C., Peters-Klimm F., H&#xfc;bner G., Thies C., et al. Time-Restricted Eating (TRE) for Obesity in General Practice: Study Protocol of a Controlled, Randomized Implementation Study (INDUCT) within the Research Practice Network Baden-Wuerttemberg (FoPraNet-BW) Nutr. J. 2025;24:36. doi: 10.1186/s12937-025-01091-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12937-025-01091-y</ArticleId><ArticleId IdType="pmc">PMC11889858</ArticleId><ArticleId IdType="pubmed">40057785</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Huang G., Wei G. Intermittent Fasting for Glycemic Control in Patients with Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. Nutr. Hosp. 2025;42:356&#x2013;365. doi: 10.20960/nh.05521.</Citation><ArticleIdList><ArticleId IdType="doi">10.20960/nh.05521</ArticleId><ArticleId IdType="pubmed">40008664</ArticleId></ArticleIdList></Reference><Reference><Citation>Parr E.B., Steventon-Lorenzen N., Johnston R., Maniar N., Devlin B.L., Lim K.H.C., Hawley J.A. Time-Restricted Eating Improves Measures of Daily Glycaemic Control in People with Type 2 Diabetes. Diabetes Res. Clin. Pract. 2023;197:110569. doi: 10.1016/j.diabres.2023.110569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2023.110569</ArticleId><ArticleId IdType="pubmed">36738837</ArticleId></ArticleIdList></Reference><Reference><Citation>Suthutvoravut U., Anothaisintawee T., Boonmanunt S., Pramyothin S., Siriyothin S., Attia J., McKay G.J., Reutrakul S., Thakkinstian A. Efficacy of Time-Restricted Eating and Behavioral Economic Intervention in Reducing Fasting Plasma Glucose, HbA1c, and Cardiometabolic Risk Factors in Patients with Impaired Fasting Glucose: A Randomized Controlled Trial. Nutrients. 2023;15:4233. doi: 10.3390/nu15194233.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15194233</ArticleId><ArticleId IdType="pmc">PMC10574576</ArticleId><ArticleId IdType="pubmed">37836517</ArticleId></ArticleIdList></Reference><Reference><Citation>Andriessen C., Fealy C.E., Veelen A., van Beek S.M.M., Roumans K.H.M., Connell N.J., Mevenkamp J., Moonen-Kornips E., Havekes B., Schrauwen-Hinderling V.B., et al. Three Weeks of Time-Restricted Eating Improves Glucose Homeostasis in Adults with Type 2 Diabetes but Does Not Improve Insulin Sensitivity: A Randomised Crossover Trial. Diabetologia. 2022;65:1710&#x2013;1720. doi: 10.1007/s00125-022-05752-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-022-05752-z</ArticleId><ArticleId IdType="pmc">PMC9477920</ArticleId><ArticleId IdType="pubmed">35871650</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus E., Vu M.H., Salvy S.J., Bakhsh J., Goran M.I., Raymond J.K., Espinoza J.C., Vidmar A.P. Randomized Controlled Feasibility Trial of Late 8-Hour Time-Restricted Eating for Adolescents With Type 2 Diabetes. J. Acad. Nutr. Diet. 2024;124:1014&#x2013;1028. doi: 10.1016/j.jand.2023.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jand.2023.10.012</ArticleId><ArticleId IdType="pmc">PMC11507361</ArticleId><ArticleId IdType="pubmed">39464252</ArticleId></ArticleIdList></Reference><Reference><Citation>Quist J.S., Pedersen H.E., Jensen M.M., Clemmensen K.K.B., Bjerre N., Ekblond T.S., Uldal S., St&#xf8;rling J., Wewer Albrechtsen N.J., Holst J.J., et al. Effects of 3 Months of 10-h per-Day Time-Restricted Eating and 3 Months of Follow-up on Bodyweight and Cardiometabolic Health in Danish Individuals at High Risk of Type 2 Diabetes: The RESET Single-Centre, Parallel, Superiority, Open-Label, Randomised Controlled Trial. Lancet Healthy Longev. 2024;5:e314&#x2013;e325. doi: 10.1016/S2666-7568(24)00028-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(24)00028-X</ArticleId><ArticleId IdType="pubmed">38588687</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlou V., Cienfuegos S., Lin S., Ezpeleta M., Ready K., Corapi S., Wu J., Lopez J., Gabel K., Tussing-Humphreys L., et al. Effect of Time-Restricted Eating on Weight Loss in Adults With Type 2 Diabetes. JAMA Netw. Open. 2023;6:e2339337. doi: 10.1001/jamanetworkopen.2023.39337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.39337</ArticleId><ArticleId IdType="pmc">PMC10611992</ArticleId><ArticleId IdType="pubmed">37889487</ArticleId></ArticleIdList></Reference><Reference><Citation>Parr E.B., Radford B.E., Hall R.C., Steventon-Lorenzen N., Flint S.A., Siviour Z., Plessas C., Halson S.L., Brennan L., Kouw I.W.K., et al. Comparing the Effects of Time-Restricted Eating on Glycaemic Control in People with Type 2 Diabetes with Standard Dietetic Practice: A Randomised Controlled Trial. Diabetes Res. Clin. Pract. 2024;217:111893. doi: 10.1016/j.diabres.2024.111893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2024.111893</ArticleId><ArticleId IdType="pubmed">39414086</ArticleId></ArticleIdList></Reference><Reference><Citation>Regmi P., Heilbronn L.K. Time-Restricted Eating: Benefits, Mechanisms, and Challenges in Translation. iScience. 2020;23:101161. doi: 10.1016/j.isci.2020.101161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101161</ArticleId><ArticleId IdType="pmc">PMC7262456</ArticleId><ArticleId IdType="pubmed">32480126</ArticleId></ArticleIdList></Reference><Reference><Citation>Parr E.B., Devlin B.L., Hawley J.A. Perspective: Time-Restricted Eating&#x2014;Integrating the What with the When. Adv. Nutr. 2022;13:699&#x2013;711. doi: 10.1093/advances/nmac015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmac015</ArticleId><ArticleId IdType="pmc">PMC9156382</ArticleId><ArticleId IdType="pubmed">35170718</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton E.F., Beyl R., Early K.S., Cefalu W.T., Ravussin E., Peterson C.M. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metab. 2018;27:1212&#x2013;1221.e3. doi: 10.1016/j.cmet.2018.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2018.04.010</ArticleId><ArticleId IdType="pmc">PMC5990470</ArticleId><ArticleId IdType="pubmed">29754952</ArticleId></ArticleIdList></Reference><Reference><Citation>Battelino T., Danne T., Bergenstal R.M., Amiel S.A., Beck R., Biester T., Bosi E., Buckingham B.A., Cefalu W.T., Close K.L., et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019;42:1593&#x2013;1603. doi: 10.2337/dci19-0028.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dci19-0028</ArticleId><ArticleId IdType="pmc">PMC6973648</ArticleId><ArticleId IdType="pubmed">31177185</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck R.W., Bergenstal R.M., Riddlesworth T.D., Kollman C., Li Z., Brown A.S., Close K.L. Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials. Diabetes Care. 2019;42:400&#x2013;405. doi: 10.2337/dc18-1444.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc18-1444</ArticleId><ArticleId IdType="pmc">PMC6905478</ArticleId><ArticleId IdType="pubmed">30352896</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>